PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.06%
Revenue growth above 1.5x 3141.T's 2.35%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
3.06%
Gross profit growth under 50% of 3141.T's 9.08%. Michael Burry would be concerned about a severe competitive disadvantage.
-44.76%
Negative EBIT growth while 3141.T is at 0.72%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-7.53%
Negative operating income growth while 3141.T is at 54.13%. Joel Greenblatt would press for urgent turnaround measures.
-34.48%
Negative net income growth while 3141.T stands at 43.60%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-34.48%
Negative EPS growth while 3141.T is at 43.58%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-34.48%
Negative diluted EPS growth while 3141.T is at 43.58%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
45.54%
10Y revenue/share CAGR under 50% of 3141.T's 160.57%. Michael Burry would suspect a lasting competitive disadvantage.
54.62%
5Y revenue/share CAGR similar to 3141.T's 57.83%. Walter Schloss might see both companies benefiting from the same mid-term trends.
25.47%
3Y revenue/share CAGR at 75-90% of 3141.T's 32.54%. Bill Ackman would expect new product strategies to close the gap.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
62.16%
Below 50% of 3141.T's 240.34%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
72.44%
5Y net income/share CAGR at 50-75% of 3141.T's 111.01%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-3.19%
Negative 3Y CAGR while 3141.T is 54.87%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
187.26%
10Y equity/share CAGR at 50-75% of 3141.T's 277.28%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
123.92%
5Y equity/share CAGR above 1.5x 3141.T's 73.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
56.65%
3Y equity/share CAGR 1.25-1.5x 3141.T's 38.59%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-21.43%
Cut dividends over 10 years while 3141.T stands at 578.86%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
57.14%
Below 50% of 3141.T's 145.45%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
22.22%
3Y dividend/share CAGR at 75-90% of 3141.T's 28.57%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
16.28%
AR growth well above 3141.T's 8.16%. Michael Burry fears inflated revenue or higher default risk in the near future.
8.26%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.92%
Asset growth at 50-75% of 3141.T's 9.76%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.38%
75-90% of 3141.T's 3.77%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
75.68%
We have some new debt while 3141.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
6.04%
We expand SG&A while 3141.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.